DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Shima M, Hanabusa H, Taki M. et al.
Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors.
Blood Adv 2017;
1 (22) 1891-1899
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.